drugset / Trial / NCT03043443

Melatonin Use for Sleep Problems in Alcohol Dependent Patients

NCT03043443

Phase 2 Completed 60 enrolled Centre for Addiction and Mental Health
RandomizedParallel-groupDouble-blindTreatment

Summary

A double blind Randomized Controlled Trial with two arms will be used. Subjects with Alcohol use disorder and sleep problems will be recruited and assigned randomly to the active treatment Melatonin or Placebo arms. All subjects will be assessed at baseline for demographics. Sleeping problems will be the primary outcome of the study, and it will be measured by the Pittsburgh sleep quality index (PSQI) scale.

Timeline

Start
2017-01-25
Primary completion
2019-01-10
Completion
2019-01-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator Melatonin Small molecule 5 mg Oral